Neil Schwartz
Biographic Data
| ID | 7972948 |
|---|---|
| NAME | Neil Schwartz |
| GIVEN NAMES | Neil |
| FAMILY NAME | Schwartz |
| SIGNATURE | SCHWARTZ N |
| ORCID | 0000-0002-5616-689X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Epd1504
Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-resistant obsessive-compulsive disorder (OCD) patients (10-50% of OCD patients). However, the utility of MOR agonists is limited by their safety liabilities. We developed a novel MOR partial agonist (EPD1540) that has an improved respiratory safety profile when compared to buprenorphine. Buprenorphine is a MOR partial agonist primarily used in the treatment of …
Building intersubjectivity in blended problem-solving tasks
No prominent works on this page.
Building intersubjectivity in blended problem-solving tasks
Epd1504
Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-resistant obsessive-compulsive disorder (OCD) patients (10-50% of OCD patients). However, the utility of MOR agonists is limited by their safety liabilities. We developed a novel MOR partial agonist (EPD1540) that has an improved respiratory safety profile when compared to buprenorphine. Buprenorphine is a MOR partial agonist primarily used in the treatment of …
Psychology (2 works) · Agonist (1 work) · Anesthesia (1 work) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 work) · Artificial Intelligence (1 work) · Buprenorphine (1 work) · Child Development and Digital Technology (1 work) · Cognitive psychology (1 work) · Computer Science (1 work) · Educational Strategies and Epistemologies (1 work)